Ventilator-associated pneumonia (VAP) is the most common nosocomial infection in the ICU
and contributes disproportionately to both poor outcomes and the high cost of care in …

Ventilator-associated pneumonia (VAP) remains a significant problem in the hospital setting,
with very high morbidity, mortality, and cost. We performed an evidence-based review of the …

Ventilator-associated pneumonia (VAP) is the most common infection seen in intensive care
units (ICUs); it accounts for one-fourth of the infections occurring in critically ill patients and is …

Ventilator-associate pneumonia (VAP) is the most common nosocomial infection in patients
in intensive care units (ICU). Because of its association with unwanted clinical outcomes …

Ventilator-associated pneumonia (VAP) accounts for approximately half of all nosocomial
pneumonia cases and remains the most common infection in patients requiring mechanical …

Despite aggressive efforts to reduce nosocomial infections, many intubated patients develop
ventilator-associated pneumonia (VAP). VAP has been an area of intense research; …

Ventilator-associated pneumonia (VAP) is associated with increased duration of mechanical
ventilation and increased risk of death for critically ill patients. Although scientific advances …

Ventilator-associated pneumonia (VAP) is an iatrogenic pulmonary infection that develops in
tracheally intubated patients on mechanical ventilation for at least 48 hours. VAP is the …

Several preventive measures have been shown to reduce the rate of VAP but many less
have demonstrated an impact on patient outcomes (noninvasive positive pressure …

Ventilator-associated pneumonia (VAP), a hospital acquired pneumonia that occurs more
than 48 h after mechanical ventilation, is a common complication of mechanical ventilation …